Randomized, double-blinded, phase II trial of a WT1 peptide vaccine as adjuvant therapy in patients with malignant pleural mesothelioma (MPM).
L. M. Krug
No relevant relationships to disclose
A. S. Tsao
No relevant relationships to disclose
S. Kass
No relevant relationships to disclose
V. W. Rusch
No relevant relationships to disclose
W. D. Travis
No relevant relationships to disclose
K. Panageas
No relevant relationships to disclose
P. S. Adusumili
No relevant relationships to disclose
M. G. Kris
No relevant relationships to disclose
P. G. Maslak
No relevant relationships to disclose
D. A. Scheinberg
No relevant relationships to disclose